Pay in 4 interest-free payments of $7.45 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Current Research Status: What Peer-Reviewed Studies Show The key evidence comes from a 2023 NEJM phase 2 trial (Jastreboff et al.)
28.3% average weight loss (~70 lbs) achieved at the 12 mg dose over 80 weeks Weight loss levels approached those historically associated with bariatric surgery 65.3% of participants on 12 mg reduced BMI below the obesity threshold ( 30% weight loss ~71 lbs (32+ kg) average weight reduction in analyses Benefits approaching bariatric surgery-level outcomes What makes Retatrutide unique
It absorbs whatever flavor you give it, provides 20 grams of protein per block serving, and sits lighter in the stomach than most animal proteins
Glucose levels are associated with mood, but the association is mediated by ratings of metabolic state
Working with Novo Nordisk, we can uniquely offer the most convenient and affordable path for patients seeking access to FDA-approved GLP-1s, said Zach Reitano, co-founder and CEO of Ro
